Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Aug 15, 2022; 14(8): 1540-1551
Published online Aug 15, 2022. doi: 10.4251/wjgo.v14.i8.1540
Published online Aug 15, 2022. doi: 10.4251/wjgo.v14.i8.1540
Table 2 5-year survival rate in adjuvant chemoradiotherapy group and adjuvant chemotherapy group
| Group | N | 5-yr survival rate (%) | Log rank test | |
| OS | All patietnts | P = 0.010 | ||
| Adjuvant chemoradiotherapy group | 57 | 66.7 | ||
| Adjuvant chemotherapy group | 295 | 41.9 | ||
| RFS | All patietnts | P = 0.254 | ||
| Adjuvant chemoradiotherapy group | 52 | 64.5 | ||
| Adjuvant chemotherapy group | 128 | 55.3 | ||
| OS | Siewert type II | P = 0.063 | ||
| Adjuvant chemoradiotherapy group | 25 | 59.3 | ||
| Adjuvant chemotherapy group | 123 | 39.4 | ||
| RFS | Siewert type II | P = 0.995 | ||
| Adjuvant chemoradiotherapy group | 22 | 60.5 | ||
| Adjuvant chemotherapy group | 58 | 55.9 | ||
| OS | Siewert type III | P = 0.006 | ||
| Adjuvant chemoradiotherapy group | 32 | 65.7 | ||
| Adjuvant chemotherapy group | 136 | 43.9 | ||
| RFS | Siewert type III | P = 0.082 | ||
| Adjuvant chemoradiotherapy group | 30 | 72.6 | ||
| Adjuvant chemotherapy group | 70 | 56.8 |
- Citation: Kang WZ, Shi JM, Wang BZ, Xiong JP, Shao XX, Hu HT, Jin J, Tian YT. Adjuvant chemoradiotherapy vs adjuvant chemotherapy in locally advanced Siewert type II/III adenocarcinoma of gastroesophageal junction after D2/R0 resection. World J Gastrointest Oncol 2022; 14(8): 1540-1551
- URL: https://www.wjgnet.com/1948-5204/full/v14/i8/1540.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i8.1540